The biotech was rumored to be a takeover target but aims to be a buyer instead.
Evidence suggests that, despite a lofty stock market, the world economy is already shrinking again.
This biotech behemoth's appeal is its combined value-and-growth stock characteristics.
Yahoo is upgraded to 'buy,' and Google is downgraded to 'market perform.'
Stocks are sharply higher following monthly jobs report for January and a better-than-expected reading on manufacturing expansion.
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
The profitable biotech's two cancer drugs could make it an attractive target.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.